Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

3, 5-dihydroxy-4-isopropyl diphenyl ethylene-ethyl bromoacetate-polyoxyethylene compound and synthetic method thereof

A technology of isopropyl stilbene and hydroxy stilbene, which is applied in the field of prodrugs of antifungal drugs, can solve the problems of inability to maintain effective blood drug concentration, low absolute bioavailability, and short biological half-life, and achieve improved Bioavailability, good water solubility, and the effect of prolonging the half-life of the drug

Inactive Publication Date: 2009-10-28
HEBEI UNIVERSITY OF SCIENCE AND TECHNOLOGY
View PDF0 Cites 7 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0002] 3,5-dihydroxy-4-isopropyl stilbene, namely styrenic modad, is a newly developed antifungal drug in Canada, but due to its poor water solubility, short biological half-life and low absolute bioavailability , clinical application requires large doses and multiple administrations to achieve the therapeutic purpose, and cannot maintain the effective blood concentration to exert a lasting therapeutic effect

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • 3, 5-dihydroxy-4-isopropyl diphenyl ethylene-ethyl bromoacetate-polyoxyethylene compound and synthetic method thereof
  • 3, 5-dihydroxy-4-isopropyl diphenyl ethylene-ethyl bromoacetate-polyoxyethylene compound and synthetic method thereof
  • 3, 5-dihydroxy-4-isopropyl diphenyl ethylene-ethyl bromoacetate-polyoxyethylene compound and synthetic method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0024]

[0025] The synthetic route of embodiment 1-embodiment 5 is as follows:

[0026]

[0027] in

[0028] Its synthetic method is carried out according to the following step order:

[0029] (1) Preparation of polyethylene glycol-ethyl diacetate

[0030] Its reaction formula is as follows:

[0031]

[0032] The operation process is as follows: take dry polyethylene glycol, dissolve in toluene, add sodium hydride or potassium tert-butoxide at a molar ratio of 1:3, stir at room temperature, add ethyl bromoacetate, and reflux for 22-25 hours; evaporate under reduced pressure Toluene was extracted with dichloromethane, concentrated under reduced pressure, anhydrous ether was added, and a white solid A was precipitated, namely polyethylene glycol-ethyl diacetate;

[0033] (2) Polyethylene glycol-diacetate hydrolysis prepares polyethylene glycol-diacetate

[0034] The reaction formula is as follows:

[0035]

[0036] The operation process is as follows: Take ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a 3, 5-dihydroxy-4-isopropyl diphenyl ethylene-ethyl bromoacetate-polyoxyethylene compound, namely polyoxyethylene-di(acetic acid-4-isopropyl-5-hydroxy diphenyl ethylene-3-phenolic ester). The original medicine is 3, 5-dihydroxy-4-isopropyl diphenyl ethylene (tolylene maud); and the modifier is polyoxyethylene and the linker arm is ethyl bromoacetate. The synthetic method of the compound includes three reactions, namely esterification reaction, hydrolysis reaction and esterification reaction. Compared with the original medicine, the compound has enhanced water-solubility and stability; the internal medicine distribution is changed; the bioavailability is enhanced; the synthetic method is simple; the reaction condition is mild; and the cost is low, without numerous unpleasant experimental procedures. In the method, the 3, 5-dihydroxy-4-isopropyl diphenyl ethylene-ethyl bromoacetate-polyoxyethylene compound can be easily made.

Description

technical field [0001] The invention relates to a prodrug of an antifungal drug, specifically a 3,5-dihydroxy-4-isopropyl stilbene-ethyl bromoacetate-polyethylene glycol complex and a synthesis method thereof . Background technique [0002] 3,5-dihydroxy-4-isopropyl stilbene, namely styrene moder, is a newly developed antifungal drug in Canada, but due to its poor water solubility, short biological half-life and low absolute bioavailability , clinical application requires large doses and multiple administrations to achieve the therapeutic purpose, and cannot maintain the effective blood concentration to exert a lasting therapeutic effect. [0003] Polyethylene glycol (PEG) has the incomparable advantages of other polymers such as good water solubility, good biocompatibility, non-toxicity and non-immunogenicity, and plays an important role in the synthesis and preparation of modified drugs. Using polyethylene glycol to modify some drugs can effectively solve the problems of...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K47/48A61K31/047A61P31/10C08G65/48A61K47/60
Inventor 张越于奕峰韩玉翠赵小林
Owner HEBEI UNIVERSITY OF SCIENCE AND TECHNOLOGY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products